DANISH BIO – DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately four "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

News

Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of High-Risk Neuroblastoma approved in Brazil 23 May 2023

May 23, 2023PDF VersionNEW YORK, May 23, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics,... Read more

Galecto Completes Dosing in 52-Week Phase 2b GALACTIC-1 Trial of GB0139 in Idiopathic Pulmonary Fibrosis 23 May 2023

BOSTON, May 23, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology... Read more

Y-mAbs Reports First Quarter 2023 Financial Results and Recent Corporate Developments and Updates 2023 Financial Guidance 08 May 2023

Q1 2023 DANYELZA® record net product revenues of $20.3 million, driving YoY growth of 93% and a 24%... Read more

Y-mAbs to Announce First Quarter 2023 Financial and Operating Results on May 8, 2023 28 April 2023

Apr 28, 2023PDF VersionNEW YORK, April 28, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics,... Read more

Y-mAbs Announces Presentation of Naxitamab data at AACR 18 April 2023

NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more

What is the right pay for your researchers? 14 April 2023

Participate now in The Danish Biotech Salary Survey to find out. Finding the right balance between salary... Read more

Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial of GD2-SADA 05 April 2023

NEW YORK, April 05, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more

Y-mAbs Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate Developments 31 March 2023

Q4 2022 DANYELZA® record net product revenues of $16.4 million, driving YoY growth of 71% and 31%... Read more

Pharm Assist is now part of LINK Medical, making the Regulatory team one of the largest and unique in Northern Europe 23 March 2023

Oslo Norway, March 23, 2023 Today LINK Medical has announced the integration of Pharm Assist into the... Read more

Copyright 2023 DANISH BIO – DANSK BIOTEK. All rights reserved.

created by: Mastafu Design